Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 14, pseudogene (RNU1-14P) is a human non-protein-coding gene classified as a pseudogene. As a pseudogene related to U1 small nuclear RNA, it is believed to be a non-functional genomic copy or relic derived from functional U1 snRNA genes, which are normally involved in pre-mRNA splicing in the spliceosome complex. Unlike active U1 snRNA genes, RNU1-14P does not produce a functional RNA product and has no current evidence of participating in biological processes or being involved in human disease, nor is it a therapeutic target[1][4][8][9]. Key clarifications: - The molecule is a pseudogene, meaning it is not expected to produce a functional RNA or protein, and is not a receptor or therapeutic target[1][8][4]. - No drugs, mechanisms of action, or biomarker roles are associated with RNU1-14P. - The entry may be conceptually incorrect for targeting or drug discovery purposes, as pseudogenes are not typical therapeutic targets. The actual, functional U1 small nuclear RNA (and its encoding genes, such as RNU1-2) participate in RNA splicing, but RNU1-14P itself does not, due to its classification as a pseudogene[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 14, pseudogene (RNU1-14P).